[ccp4bb] PDRA position in antiviral drug discovery at Diamond Light Source

Dear all, We are currently recruiting for a Post-Doctoral Research Associate within the XChem/I04-1 team at Diamond Light Source to drive high-throughput fragment screening experiments and structural biology support for hit-to-lead development as part of our NIH-funded Anti-Viral Drug Discovery

[ccp4bb] XChem access: Diamond AP32 Call for Proposals open until 30 March 2022

Hi all, Friendly reminder that the Diamond AP32 call for proposals (which includes XChem access between October 2022 and March 2023) is open until Wednesday 30th March at 17:00hrs UTC/GMT+1. Please check our webpage

[ccp4bb] Rapid access to COVID-19 related fragment screening

Dear all, As part of Diamond's effort to combat COVID-19, we are offering fragment screening expertise and infrastructure to users working on COVID-19 related targets (as demonstrated by the recent fragment screening campaign against SAR-CoV-2 Main protease